Based on the demonstrated function of THIK-1 in modulating NLRP3 inflammasome activation, together with its disease related changes in expression, we believe that molecules such as C101248 may have therapeutic utility in the treatment of neurodegenerative diseases where microglial mediated neuroinflammation is a key underlying driver of progression. Here, KCNK13 is linked to neurodegenerative disease.